Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients
Copyright © 2022 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved..
SARS-CoV-2 infection (COVID-19) has had a significant impact on transplant activity in our country. Mortality and the risk of complications associated with COVID-19 in kidney transplant recipients (KT) were expected to be higher due to their immunosuppressed condition and the frequent associated comorbidities. Since the beginning of the pandemic in March 2020 we have rapidly improved our knowledge about the epidemiology, clinical features and management of COVID-19 post-transplant, resulting in a better prognosis for our patients. KT units have been able to adapt their programs to this new reality, normalizing both donation and transplantation activity in our country. This manuscript presents a proposal to update the general recommendations for the prevention and treatment of infection in this highly vulnerable population such as KT.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Nefrologia - 43(2023), 5 vom: 13. Sept., Seite 531-545 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
López, Verónica [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 04.12.2023 Date Revised 30.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.nefroe.2023.10.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364487526 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364487526 | ||
| 003 | DE-627 | ||
| 005 | 20240131231942.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nefroe.2023.10.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1276.xml |
| 035 | |a (DE-627)NLM364487526 | ||
| 035 | |a (NLM)37957107 | ||
| 035 | |a (PII)S2013-2514(23)00169-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a López, Verónica |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.12.2023 | ||
| 500 | |a Date Revised 30.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a SARS-CoV-2 infection (COVID-19) has had a significant impact on transplant activity in our country. Mortality and the risk of complications associated with COVID-19 in kidney transplant recipients (KT) were expected to be higher due to their immunosuppressed condition and the frequent associated comorbidities. Since the beginning of the pandemic in March 2020 we have rapidly improved our knowledge about the epidemiology, clinical features and management of COVID-19 post-transplant, resulting in a better prognosis for our patients. KT units have been able to adapt their programs to this new reality, normalizing both donation and transplantation activity in our country. This manuscript presents a proposal to update the general recommendations for the prevention and treatment of infection in this highly vulnerable population such as KT | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Immunosuppressed | |
| 650 | 4 | |a Inmunodeprimidos | |
| 650 | 4 | |a Kidney transplantation | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Trasplante de riñón | |
| 700 | 1 | |a Mazuecos, Auxiliadora |e verfasserin |4 aut | |
| 700 | 1 | |a Villanego, Florentino |e verfasserin |4 aut | |
| 700 | 1 | |a López-Oliva, María |e verfasserin |4 aut | |
| 700 | 1 | |a Alonso, Angel |e verfasserin |4 aut | |
| 700 | 1 | |a Beneyto, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Crespo, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Díaz-Corte, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Franco, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a González-Roncero, Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a Guirado, Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Jiménez, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Juega, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Llorente, Santiago |e verfasserin |4 aut | |
| 700 | 1 | |a Paul, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Benot, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz, Juan Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez-Fructuoso, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Torregrosa, Vicente |e verfasserin |4 aut | |
| 700 | 1 | |a Zárraga, Sofía |e verfasserin |4 aut | |
| 700 | 1 | |a Rodrigo, Emilio |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández, Domingo |e verfasserin |4 aut | |
| 700 | 0 | |a Grupo de Estudio GREAT y SENTRA |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nefrologia |d 2018 |g 43(2023), 5 vom: 13. Sept., Seite 531-545 |w (DE-627)NLM270991409 |x 2013-2514 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2023 |g number:5 |g day:13 |g month:09 |g pages:531-545 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nefroe.2023.10.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2023 |e 5 |b 13 |c 09 |h 531-545 | ||